Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient Response From the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials. J of Skin 2023, 7 (6), s252. https://doi.org/10.25251/skin.7.supp.252.